China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. The company operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. It offers a range of chemical drugs, Chinese medicines, and biopharmaceutical drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. The company also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it is involved in property holding activities. As of December 31, 2021, the company operated 801 retail pharmacies under the CR Care and Teck Soon Hong brands. It distributes its products to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
China Resources Pharmaceutical Dividend Announcement
• China Resources Pharmaceutical announced a semi annually dividend of HK$0.09 per ordinary share which will be made payable on 2024-10-30. Ex dividend date: 2024-09-10
• China Resources Pharmaceutical annual dividend for 2024 was HK$0.26
• China Resources Pharmaceutical annual dividend for 2023 was HK$0.16
• China Resources Pharmaceutical's trailing twelve-month (TTM) dividend yield is 6.25%
• China Resources Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 24.03%
• China Resources Pharmaceutical's dividend growth over the last five years (2018-2023) was 7.78% year
China Resources Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-10 | HK$0.09 | semi annually | 2024-10-30 |
2024-06-04 | HK$0.17 | semi annually | 2024-07-19 |
2023-06-05 | HK$0.16 | semi annually | 2023-07-21 |
2022-06-06 | HK$0.15 | semi annually | 2022-07-25 |
2021-06-02 | HK$0.12 | semi annually | 2021-06-23 |
2020-06-29 | HK$0.11 | semi annually | 2020-07-20 |
2020-06-03 | HK$0.11 | semi annually | |
2019-06-03 | HK$0.13 | semi annually | 2019-06-21 |
2018-05-23 | HK$0.11 | semi annually | 2018-06-08 |
2017-05-24 | HK$0.09 | semi annually | 2017-06-09 |
China Resources Pharmaceutical Dividend per year
China Resources Pharmaceutical Dividend growth
China Resources Pharmaceutical Dividend Yield
China Resources Pharmaceutical current trailing twelve-month (TTM) dividend yield is 6.25%. Interested in purchasing China Resources Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
China Resources Pharmaceutical Financial Ratios
China Resources Pharmaceutical Dividend FAQ
Other factors to consider when evaluating China Resources Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy China Resources Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: China Resources Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, China Resources Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, China Resources Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from China Resources Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: China Resources Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, China Resources Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: China Resources Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of China Resources Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review China Resources Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.